Non-caloric Sweeteners Levels in Breast Milk and Newborn's Blood and Effect on Microbiota's Composition.

September 20, 2023 updated by: Marcela Esquivel V, Hospital General de México Dr. Eduardo Liceaga
This study evaluates the presence and quantity of non-caloric sweeteners in newborns umbilical cord blood, and in their mother's breast milk at delivery, at 2 months, 4 months and 6 months of age. Microbiota composition will be evaluated in milk and in feces of both mother and child.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

The consumption of non-caloric sweeteners (ENC) is increasingly common in our country due to its wide use in all types of food and beverages, even those not labeled as "diet". Despite its widespread use and being an alternative to the consumption of sugars, several studies have shown that frequent ENC users are also at risk of excessive weight gain, type II diabetes, and cardiovascular diseases. In addition to this, the consumption of ENC in the early stages of life may predispose to the development of metabolic disorders later in life.The ENC have been shown to have effects on the health of those who consume them, causing metabolic disorders, weight gain and changes in the microbiota. The newborns, in whom gut microbiota is in the process of being established, influenced by the vaginal and intestinal microbiota of the mother, as well as by the mother's milk, are a vulnerable population in whom the effect of ENC consumption has not been investigated. This makes it relevant to study the prevalence of ENC in breast milk and umbilical cord blood of their newborns and to evaluate the composition of the intestinal and milk microbiota in order to identify changes attributable to the consumption of ENC.

Study Type

Observational

Enrollment (Actual)

178

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Mexico City, Mexico, 06726
        • General Hospital of Mexico Dr. Eduardo Liceaga

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 40 years (Adult)

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Women in labor who come to the service of gynecology and obstetrics General Hospital Mexico. Usually, they are residents from Mexico City and metropolitan area (Mexico State).

Description

Inclusion Criteria:

  • Age 18-40 years old
  • Women in labor
  • Consent to participate in the study

Exclusion Criteria:

  • Pre-term delivery (<30 weeks)
  • Metabolic diseases (insulin resistance, diabetes, gestational diabetes)
  • Hypertension
  • Thyroid disease
  • Cancer

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Null or low consumption
No-intervention. The group consists of women who have reported a null or low consumption of non-caloric sweeteners during late pregnancy.
No intervention
Moderate consumption
No-intervention. The group consists of women who have reported a moderate consumption of non-caloric sweeteners during late pregnancy.
No intervention
High consumption
No-intervention. The group consists of women who have reported a high consumption of non-caloric sweeteners during late pregnancy.
No intervention

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Microbiota composition in feces
Time Frame: 2 months
Composition of feces microbiota in mother and newborn
2 months
Microbiota composition in feces
Time Frame: 4 months
Composition of feces microbiota in mother and newborn
4 months
Microbiota composition in feces
Time Frame: 6 months
Composition of feces microbiota in mother and newborn
6 months
Microbiota composition in breast milk
Time Frame: 0 months
Composition of breast milk microbiota
0 months
Microbiota composition in breast milk
Time Frame: 2 months
Composition of breast milk microbiota
2 months
Microbiota composition in breast milk
Time Frame: 4 months
Composition of breast milk microbiota
4 months
Microbiota composition in breast milk
Time Frame: 6 months
Composition of breast milk microbiota
6 months
Non-caloric sweeteners levels at birth
Time Frame: at birth
Non-caloric sweeteners levels in milk, plasma, umbilical cord plasma, urine in mg/mL
at birth
Non-caloric sweeteners levels 2 months follow-up
Time Frame: 2 months after birth
Non-caloric sweeteners levels in breast milk and urine in the 2 months follow-up
2 months after birth
Non-caloric sweeteners levels 4 months follow-up
Time Frame: 4 months after birth
Non-caloric sweeteners levels in breast milk and urine in the 4 months follow-up
4 months after birth
Non-caloric sweeteners levels 6 months follow-up
Time Frame: 6 months after birth
Non-caloric sweeteners levels in breast milk and urine in the 6 months follow-up
6 months after birth

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Marcela Esquivel, PhD, Hospital General de México Dr. Eduardo Liceaga

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 26, 2018

Primary Completion (Actual)

December 31, 2022

Study Completion (Actual)

December 31, 2022

Study Registration Dates

First Submitted

April 8, 2019

First Submitted That Met QC Criteria

April 9, 2019

First Posted (Actual)

April 11, 2019

Study Record Updates

Last Update Posted (Actual)

September 21, 2023

Last Update Submitted That Met QC Criteria

September 20, 2023

Last Verified

September 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • DI/17/301/05/075

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Microbial Colonization

Clinical Trials on No intervention.

3
Subscribe